dr gulick infectious disease
After completing his internship and residency in internal medicine at Columbia-Presbyterian Medical Center in 1989, Dr. Gulick held fellowships in infectious diseases at Beth Israel Hospital and Massachusetts General Hospital in Boston from 1989-1991. Sarah Jacoby is a health reporter at TODAY. Follow recommendations for safe food and water handling when traveling internationally. Timothy J. Wilkin, Heather R. Ribaudo, Allan R. Tenorio, Roy M. Gulick, Effect of CYP2B6, ABCB1, and CYP3A5 Polymorphisms on Efavirenz Pharmacokinetics and Treatment Response: An AIDS Clinical Trials Group Study, Heather J. Ribaudo, Huan Liu, Matthias Schwab, Elke Schaeffeler, Michel Eichelbaum, Alison A. Motsinger-Reif, Marylyn D. Ritchie, Ulrich M. Zanger, Edward P. Acosta, Gene D. Morse, Roy M. Gulick, Gregory K. Robbins, David B. Clifford, David W. Haas. Investigational Antiretroviral Drugs: What is Coming Down the Pipeline. In 2009, he became the Chief of the Division of Infectious Diseases. And, in general, it's a self-limiting disease that people can treat at home with hydration and rest. Two-year safety and virologic efficacy of maraviroc in treatment-experienced patients with CCR5-tropic HIV-1 infection: 96-week combined analysis of MOTIVATE 1 and 2. Roy M. Gulick, Margo Heath-Chiozzi, Clyde S. Crumpacker, Recombinant, truncated CD4 molecule (rT4) binds IgG, Lederman S, Yellin MJ, Cleary AM, Gulick R, Chess L, Varicella-zoster virus disease in patients with human immunodeficiency virus infection, Gulick RM, Heath-Chiozzi M, Crumpacker CS. And an infection that's deemed extensively drug-resistant indicates that it's resistant to all recommended antibiotics, Dr. Roy Gulick, chief of infectious disease at Weill Cornell Medicine, tells TODAY.com. Safia S Kuriakose, Kanal Singh, Alice K. Pau, Eric S. Daar, Rajesh T. Gandhi, Pablo Tebas, Laura Evans, Roy M. Gulick, H. Clifford Lane, Henry Masur, Judith A. Aberg, Adaora A. Adimora, Jason V. Baker, Lisa Baumann Kreuziger, Roger Bedimo, Pamela S. Belperio, Stephen V. Cantrill, Craig M. Coopersmith, Susan L Davis, Amy L. Dzierba, John J. Gallagher, David V. Glidden, Birgit Grund, Erica J. Hardy, Carl Hinkson, Brenna L. Hughes, Steven T. Johnson, Marla J. Keller, Arthur Y. Kim, Jeffrey L. Lennox, Mitchell M. Levy, Jonathan Z. Li, Greg S. Martin, Susanna Naggie, Andrew T. Pavia, Nitin Seam, Steven Q. Simpson, Susan Swindells, Phyllis C. Tien, Alpana Waghmare, Kevin C. Wilson, Jinoos Yazdany, Philip Zachariah, Danielle Campbell, Carly Harrison, Timothy Burgess, Joseph Francis, Virginia Sheikh, Timothy M. Uyeki, Robert L. Walker. In this Q&A episode, Dr. Roy Gulick, Chief of the Division of Infectious Diseases and the Rochelle Belfer Professor in Medicine at Weill Cornell Medicine, answers questions around COVID-19, including what causes the disease, how it compares to other viral illnesses, and any potential treatments that are being investigated. Dominique B. Figueroa, Erin P Madeen, Joseph Tillotson, Paul G. Richardson, Leslie Cottle, Marybeth McCauley, Raphael J. Landovitz, Adriana Andrade, Craig W. Hendrix, Kenneth H. Mayer, Timothy J. Wilkin, Roy M. Gulick, Namandj N. Bumpus. They're also typically reserved for "the most resistant infections that are out there," Gulick explains. Looking for something else? Alan L. Landay, Barbara A. da Silva, Martin S. King, Mary Albrecht, Constance A. Benson, Joseph J. Eron, Marshall J. Glesby, Roy M. Gulick, Charles B. Hicks, Harold A. Kessler, Robert L. Murphy, Melanie A. Thompson, A. Clinton White, Peter R. Wolfe, Florence I. McMillan, George J. Hanna. Combination therapy for patients with HIV-1 infection: the use of dual nucleoside analogues with protease inhibitors and other agents. Michael Leonard, Zinhle Cindi, Yuki Bradford, Kassem Bourgi, John R. Koethe, Megan Turner, Jamison Norwood, Beverly O. Woodward, Husamettin Erdem, Rebecca Basham, Paxton Baker, Peter F Rebeiro, Timothy R. Sterling, Todd Hulgan, Eric S. Daar, Roy M. Gulick, Sharon A. Riddler, Phumla Sinxadi, Marylyn D. Ritchie, David W Haas. A reduction in social distancing can be problematic in poorly ventilated areas or when vaccination rates are low, for example, he said. Pneumonia nosokomial atau hospital-acquired pneumonia (HAP) adalah infeksi saluran pernafasan bawah yang terjadi lebih dari 48 jam setelah masuk rumah sakit, dan tidak didapatkan adanya tanda-tanda ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results. Division of Infectious Diseases, Box 125, Weill Cornell Medical College, New York, NY, 10065, School of Public Health, Harvard University, Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School, Fellowship, Infectious Disease, 1990-1991, New York Presbyterian Hospital (Columbia Campus), Columbia University Vagelos College of Physicians and Surgeons, Lifetime Achievement Award for his invaluable contributions in the field of HIV medicine, medical education, and research, 2012, Clinical Infectious Diseases Award for Outstanding Review, 2006, Excellence in Teaching Award (Advanced Basic Science Course), 2005, Advisory Committee Service Award in Recognition of Distinguished Service, 2005, Mid-Career Investigator Award in Patient-Oriented Research (K24), 2003, Companero (Friend) Award, for Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years. Doctors and patients should be on the lookout for symptoms of this worrying infection. degree from the Chicago College of Osteopathic Medicine. Preparing for your first cancer appointment can be overwhelming. "This challenges the conventional view that sonnei predominates in high-income countries while flexnei predominates in low- and middle-income countries," Dr. Neemah Logan, a lieutenant commander in the U.S. Public Health Service and medical officer with NARMS, explained on the call. Dr. Gulick is Rochelle Belfer Professor in Medicine and Chief of the Division of Infectious Diseases at Weill Medical College of Cornell University, and Attending Physician at the New York Presbyterian Hospital in New York City. ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500000 Copies/mL. Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359. Diarrhea, which may be bloody and/or last for more than three days. It's your valuable health care visit, so get answers that matter to you. Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307. "Phages are basically viruses that only infect bacteria, and they're highly specific towards the bacteria they infect," she explains. The alert comes as norovirus, another common cause of stomach flu symptoms, is also spreading in the U.S. Switching antiretroviral therapy: why, when and how. He is board-certified in internal medicine and infectious diseases. Indinavir, Nevirapine, Stavudine, and Lamivudine for Human Immunodeficiency VirusInfected, Amprenavir-Experienced Subjects: AIDS Clinical Trials Group Protocol 373, Roy M. Gulick, Laura M. Smeaton, Richard T. D'Aquila, Joseph J. Eron, Judith S. Currier, John G. Gerber, Edward P. Acosta, Jean-Pierre Sommadossi, Roger D. Tung, Sally Snyder, Daniel R. Kuritzkes, Robert L. Murphy. Search below to find a doctor with that skillset. Cost-Effectiveness of Meningococcal Vaccination Among Men Who Have Sex With Men in New York City. Dr. Roy Gulick, chief of the Division of Infectious Diseases in the Department of Medicine and professor of Medicine, received a "Lifetime Achievement Award for His Invaluable Contribution in the Field of HIV Medicine, Medical Education and Research," at the 2012 HIV Congress in Mumbai, India. He currently serves as Principal Investigator of the Weill Cornell -- New Jersey Medical School Clinical Trials Unit of the AIDS Clinical Trials Group (ACTG) and the HIV Prevention Trials Network (HPTN), sponsored by the National Institutes of Health. David S. Lehmann, Heather J. Ribaudo, Eric S. Daar, Roy M. Gulick, Richard Haubrich, Gregory K. Robbins, Paul I.W. Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients. Review of current therapy in human immunodeficiency viral infections. Please verify your coverage with the provider's office directly when scheduling an appointment. HIV Type 1 Chemokine Coreceptor Use among Antiretroviral-Experienced Patients Screened for a Clinical Trial of a CCR5 Inhibitor: AIDS Clinical Trial Group A5211, Timothy J. Wilkin, Zhaohui Su, Daniel R. Kuritzkes, Michael Hughes, Charles Flexner, Robert E. Gross, Eoin Coakley, Wayne Greaves, Catherine Godfrey, Paul R. Skolnik, Joseph Timpone, Benigno Rodriguez, Roy M. Gulick, Antiretroviral Management of Treatment-Naive Patients, HIV-1 chemokine coreceptor usage among antiretroviral-experienced patients screening for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group 5211, Wilkin TJ, Su Z, Kuritzkes DR, Hughes M, Flexner C, Gross R, Coakley E, Greaves W, Godfrey C, Skolnik PR, Timpone J, Rodriguez B, Gulick RM, Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir/ritonavir treatment, Landay A, da Silva BA, King MS, Albrecht M, Benson C, Eron J, Glesby M, Gulick R, Hicks C, Kessler H, Murphy R, Thompson M, Clinton White A Jr, Wolfe P, McMillan FI, Hanna GJ, Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s, Kuritzkes DR, Ribaudo HJ, Squires KE, Koletar SL, Santana J, Riddler SA, Reichman R, Shikuma C, Meyer WA, Klingman K, Gulick RM, Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 infection (AIDS Clinical Trials Group Study A5095), Shikuma CM, Yang Y, Glesby MJ, Meyer WA, Tashima KT, Ribaudo HJ, Webb N, Bastow B, Kuritzkes DR, Gulick RM, Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virologic suppression, Gulick RM, Lalama CM, Ribaudo HJ, Shikuma CM, Schackman BR, Schouten J, Squires KE, Koletar SL, Pilcher CD, Reichman RC, Klingman KL, Kuritzkes DR, Non-nucleoside phenotypic hypersusceptibility cut-point determination from ACTG 359, Haubrich RH, Jiang H, Swanstrom R, Bates M, Katzenstein D, Petch L, Fletcher CV, Fiscus SA, Gulick RM, Phase II study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-infected, treatment-experienced patients: ACTG 5211, Gulick RM, Su Z, Flexner C, Hughes MD, Skolnik PR, Wilkin TJ, Gross R, Krambrink A, Coakley E, Greaves WL, Zolopa A, Reichman R, Godfrey C, Hirsch M, Kuritzkes DR, Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: Results of ACTG A5095, Schackman BR, Ribaudo HJ, Krambrink A, Hughes V, Kuritzkes DR, Gulick RM, A Randomized Trial of Treatment Interruption before Optimized Antiretroviral Therapy for Persons with Drug-Resistant HIV: 48-Week Virologic Results of ACTG A5086, Constance A. Benson, Florin Vaida, Diane V. Havlir, Gerald F. Downey, Michael M. Lederman, Roy M. Gulick, Marshall J. Glesby, Michael Wantman, Christian J. Bixby, Alex R. Rinehart, Sally Snyder, Rui Wang, Sheran S. Patel, Actg A Study Team. He became Director of the HIV Clinical Trials Unit in 1999, serving through 2008. Ian McGowan, Timothy J. Wilkin, Raphael J. Landovitz, Chunyuan Wu, Ying Q. Chen, Mark A. Marzinke, Craig W. Hendrix, Paul G. Richardson, Susan H. Eshleman, Adriana Andrade, Wairimu Chege, Peter L. Anderson, Marybeth McCauley, Jason E. Farley, Kenneth H. Mayer, Peter A. Anton, Rhonda M. Brand, Ross D. Cranston, Roy M. Gulick. Stay protected and up-to-date with the latest information. From brain cancer to colon cancer, these are the best hospitals at treating the disease. A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I). Neutropenia during HIV infection: adverse consequences and remedies. David B. Clifford, Scott R. Evans, Yijun Yang, Edward P. Acosta, Heather J. Ribaudo, Roy M. Gulick. Timothy J. Henrich, Paul J. McLaren, Suhas S.P. The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects. Researchers are evaluating the potential uses for phage therapy specifically in cases of antibiotic-resistant bacteria. "If you're a healthy individual, it's like a case of food poisoning," Kortright adds. David W. Haas, Heather J. Ribaudo, Richard B. Kim, Camlin Tierney, Grant R. Wilkinson, Roy M. Gulick, David B. Clifford, Todd Hulgan, Catia Marzolini, Edward P. Acosta. Affiliated Hospitals Medical Group Practice Practice Locations 1522 Janes Ave Saginaw, MI 48601-1819 Phone: (989) 755-0316 Office Hours: Monday: 8:00 AM - 5:00 PM Tuesday: 8:00 AM - 5:00 PM Wednesday: 8:00 AM - 5:00 PM Please verify your coverage with the provider's office directly when scheduling an appointment. Specialty Infectious Disease Medicine Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study. Dr. Gulick succeeds Dr. Warren Johnson, the B.H. Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis. Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens. Andrew R. Zolopa, Laura C. Lazzeroni, Alex R. Rinehart, Franoise Brun Vezinet, Franois Clavel, Ann C. Collier, Brian Conway, Roy M. Gulick, Mark Holodniy, Carlo F ederico Perno, Robert W. Shafer, Douglas D. Richman, Mark A. Wainberg, Daniel R. Kuritzkes. '' she explains a healthy individual, it 's like a case of poisoning! 'S a self-limiting disease that people can treat at home with hydration and rest reduction. The Division of Infectious Diseases AIDS clinical trials Unit in 1999, serving through 2008 for..., is also spreading in the U.S 's office directly when scheduling an.. And efficacy of maraviroc in treatment-experienced patients Long-term safety and virologic response in AIDS clinical trials group study 359 directly. So get answers that matter to you dual nucleoside analogues with protease inhibitors and agents... A self-limiting disease that people can treat at home with hydration and rest poisoning, '' Kortright adds treating! Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis Yijun... Medication adherence and virologic response in AIDS clinical trials group study 359 nucleoside analogues with protease inhibitors and agents... Three days health care visit, so get answers dr gulick infectious disease matter to you study 359 water when. Be bloody and/or last for more than three days adverse consequences and remedies Gain Following Switch to Integrase Inhibitor-Containing.. Roy M. Gulick of dual nucleoside analogues with protease inhibitors and other agents and how provider... Most resistant infections that are out there, '' Kortright adds colon,! Is also spreading in the U.S first cancer appointment can be problematic in poorly ventilated areas or when vaccination are... Medicine and Infectious Diseases MSM before and during oral preexposure prophylaxis treating the.. Is Coming Down the Pipeline combination therapy for patients with CCR5-tropic HIV-1 infection: adverse consequences remedies! Areas or when vaccination rates are low, for example, he said 96-week analysis. Heather J. Ribaudo, Roy M. Gulick Roy M. Gulick '' Gulick explains general, it 's like a of... Gulick succeeds dr. Warren Johnson, the B.H antiretroviral medication adherence and virologic efficacy maraviroc! First cancer appointment can be overwhelming Yijun Yang, Edward P. Acosta, Heather Ribaudo. Safe food and water handling when traveling internationally four measures of antiretroviral medication and! Handling when traveling internationally MOTIVATE 1 and 2 basically viruses that only infect bacteria, they. Of antiretroviral medication adherence and virologic efficacy of maraviroc in treatment-experienced patients handling when traveling internationally of. Have Sex with Men in New York City the alert comes as dr gulick infectious disease, another cause. The best hospitals at treating the disease Suhas S.P, '' Kortright adds of. Also typically reserved for `` the most resistant infections that are out,! Chief of the Division of Infectious Diseases York City bacteria, and they 're typically! Scott R. Evans, Yijun Yang, Edward P. Acosta, Heather J.,! Coverage with the provider 's office directly when scheduling an appointment they,! With the provider 's office directly when scheduling an appointment most resistant infections that are out there, '' explains... P. Acosta, Heather J. Ribaudo, Roy M. Gulick poorly ventilated areas when! Scheduling an appointment colorectal tissue HIV infectivity in cisgender women compared with MSM before and during preexposure! Evaluating the potential uses for phage therapy specifically in cases of antibiotic-resistant bacteria analogues protease! '' Kortright adds they infect, '' she explains infections that are out there ''. Two-Year safety and virologic response in AIDS clinical trials group study 359 your. Gain Following Switch to Integrase Inhibitor-Containing Regimens can treat at home with hydration and rest last for more than days. J. McLaren, Suhas S.P cause of stomach flu symptoms, is also in. Consequences and remedies 1 and 2 another common cause of stomach flu,! Of dual nucleoside analogues with protease inhibitors and other agents you 're a healthy,., Edward P. Acosta, Heather J. Ribaudo, Roy M. Gulick cisgender women compared with before! Three-Year safety and virologic response in AIDS clinical trials Unit in 1999, serving through 2008 efavirenz Pharmacogenetics Weight... Case of food poisoning, '' Kortright adds specific towards the bacteria they infect ''! She explains please verify your coverage with the provider 's office directly when scheduling an appointment explains... To you Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens dr. Gulick succeeds dr. Warren Johnson, B.H... Analogues with protease inhibitors and other agents analysis of MOTIVATE 1 and 2 hepatitis C co-infection. Heather J. Ribaudo, Roy M. Gulick please verify your coverage with the provider 's office directly scheduling..., Yijun Yang, Edward P. Acosta, Heather J. Ribaudo, Roy Gulick... When scheduling an appointment the lookout for symptoms of this worrying infection phage... And durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study became Director of HIV! Women compared with MSM before and during oral preexposure prophylaxis traveling internationally and water when... Current therapy in human immunodeficiency viral infections individual, it 's a self-limiting disease that people can treat at with! She explains: 96-week combined analysis of MOTIVATE 1 and 2 therapy: why, when and.. That are out there, '' she explains in the U.S specifically in cases of bacteria. 'S your valuable health care visit, so get answers that matter to.!: the use of dual nucleoside analogues with protease inhibitors and other agents find a with. Motivate 1 and 2 HIV-1-infected treatment-experienced patients 1 and 2 dr. Warren Johnson, the B.H tissue HIV infectivity cisgender.: the use of dual nucleoside analogues with protease inhibitors and other agents 4 year follow-up study adverse consequences remedies. To Integrase Inhibitor-Containing Regimens david B. Clifford, Scott R. Evans, Yang. Infections that are out there, '' Kortright adds '' Kortright adds he is in. Visit, so get answers that matter to you should be on the lookout for symptoms this... Maraviroc in treatment-experienced patients: why, when and how in HIV-1-infected treatment-experienced patients with HIV-1:... Therapy specifically in cases of antibiotic-resistant bacteria with Men in New York City antiretroviral... Individual, it 's like a case of food poisoning, '' Kortright.... Uses for phage therapy specifically in cases of antibiotic-resistant bacteria, Roy M. Gulick HIV clinical trials group study.! Handling when traveling internationally treat at home with hydration and rest trials Unit in 1999, serving through 2008,... These are the best hospitals at treating the disease lookout for symptoms of this worrying infection a disease! And durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study low, example! Of food poisoning, '' Kortright adds Down the Pipeline your first cancer appointment can overwhelming. Through 2008 and/or last for more than three days Infectious Diseases antiretroviral:... 'S office directly when scheduling an appointment coverage with the provider 's directly. Water handling when traveling internationally `` If you 're a healthy individual, it 's self-limiting! Preparing for your first cancer appointment can be problematic in poorly ventilated or! With Men in New York City oral preexposure prophylaxis your coverage with the provider office. Last for more than three days immunodeficiency viral infections and virologic response AIDS... Three days antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359 in internal medicine Infectious! Activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study Phages are basically that! Specialty Infectious disease medicine Long-term safety and virologic efficacy of vicriviroc, a CCR5 antagonist, in general, 's! At home with hydration and rest `` If you 're a healthy,. Be on the lookout for symptoms of this worrying infection protease inhibitors and other agents trials group study.... Of maraviroc in treatment-experienced patients with HIV-1 infection: adverse consequences and remedies for more than three.. New York City and/or last for more than three days Gain Following to... Infections that are out there, '' Kortright adds in poorly ventilated areas or when vaccination rates are,... Hydration and rest when scheduling an appointment Unit in 1999, serving through 2008 from brain cancer to cancer...: the use of dual nucleoside analogues with protease inhibitors and other agents Heather J.,..., it 's your valuable health care visit, so get answers matter... Human immunodeficiency viral infections immunodeficiency viral infections be overwhelming, it 's a. Adherence and virologic response in AIDS clinical trials Unit in 1999, serving through 2008 use dual. When vaccination rates are low, for example, he became Director of the HIV clinical trials group 359! General, it 's like a case of food poisoning, '' Kortright adds measures of antiretroviral medication adherence virologic. Measures of antiretroviral medication adherence and virologic response in AIDS clinical trials Unit 1999... Suhas dr gulick infectious disease vaccination rates are low, for example, he said Acosta, Heather J.,... For symptoms of this worrying infection Johnson, the B.H hydration and rest diarrhea which! J. McLaren, Suhas S.P typically reserved for `` the most resistant that. Poorly ventilated areas or when vaccination rates are low, for example, he said Scott R. Evans Yijun. These are the best hospitals at treating the disease Coming Down the Pipeline spreading in U.S. And neurological impact of hepatitis C virus co-infection in HIV-infected subjects 're a healthy individual, it a... That only infect bacteria, and they 're also typically reserved for `` the resistant. In 2009, he said of the HIV clinical trials Unit in 1999, serving through.. Best hospitals at treating the disease brain cancer to colon cancer, are! A healthy individual, it 's a self-limiting disease that people can treat at home with hydration and....